| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 648.482 | 602.420 | 595.605 | 618.341 | 631.762 | 663.512 | 658.265 | 707.386 | 798.938 | 944.124 |
| Total Income - EUR | 654.663 | 604.106 | 597.775 | 630.712 | 632.241 | 678.562 | 665.160 | 715.792 | 811.226 | 946.006 |
| Total Expenses - EUR | 615.901 | 572.028 | 570.949 | 593.968 | 602.057 | 642.982 | 633.156 | 671.504 | 752.731 | 883.329 |
| Gross Profit/Loss - EUR | 38.763 | 32.078 | 26.825 | 36.743 | 30.185 | 35.580 | 32.004 | 44.288 | 58.495 | 62.677 |
| Net Profit/Loss - EUR | 32.231 | 26.932 | 22.417 | 30.259 | 25.153 | 27.769 | 26.257 | 36.976 | 50.191 | 53.150 |
| Employees | 8 | 7 | 8 | 8 | 9 | 8 | 7 | 7 | 7 | 7 |
Check the financial reports for the company - Viofarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.413 | 3.911 | 3.413 | 32.428 | 24.730 | 16.714 | 10.043 | 3.014 | 1.987 | 2.997 |
| Current Assets | 193.211 | 169.745 | 168.038 | 167.764 | 176.617 | 203.970 | 182.625 | 211.533 | 244.201 | 278.209 |
| Inventories | 135.727 | 112.430 | 115.106 | 102.208 | 118.019 | 123.985 | 103.438 | 124.308 | 136.404 | 139.713 |
| Receivables | 43.895 | 24.884 | 43.349 | 60.993 | 54.164 | 67.359 | 52.681 | 60.628 | 83.353 | 92.301 |
| Cash | 13.589 | 32.431 | 9.583 | 4.564 | 4.435 | 12.625 | 26.506 | 26.597 | 24.445 | 46.194 |
| Shareholders Funds | 40.276 | 34.896 | 30.256 | 40.016 | 34.723 | 37.170 | 35.454 | 46.219 | 61.156 | 64.054 |
| Social Capital | 2.250 | 2.227 | 2.189 | 9.713 | 9.525 | 9.344 | 9.137 | 9.166 | 9.138 | 9.087 |
| Debts | 157.348 | 138.759 | 141.194 | 160.176 | 166.625 | 183.513 | 157.214 | 168.328 | 185.032 | 217.152 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Viofarm S.r.l.